DP-16

N/A

Report date: 2023/02/11 20:37:57
NME

Base Information

Drug NameDP-16
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChelating agents
TargetsUpdating
Therapy Area/IndicationsVentricular Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesD-Pharm Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesD-Pharm Ltd
Active IndicationsN/A
Inactive IndicationsVentricular Fibrillation

Other Information

ATC CodeN/A
Related LinksN/A